Azzouz and Bullerman, Journal of Food Protection, 12/82, 45:14,1298-1301; this paper examined a variety of herbs and spices. Oregano was one of them that completely inhibited 7 mycotoxin-producing molds. Pauli and Knobloch, Institute for Botanical and Pharmaceutical Biology, Nurnburg University, Nurburg, Germany, 87; 185:10-13; this study demonstrated that carvacrol, the major ingredient of the oil of oregano, was an effective anti-fungal agent using molds and fungi that commonly contaminate food. Akgul and Kivanc, International Journal of Food Microbiology, 6(88):263-268; this study demonstrated that oil of oregano inhibited Geotrichum and Aspergillus (Geotrichum is known to cause gastro-intestinal symptoms with overgrowth). They also note that of the ten herbs and spices examined, only oregano inhibited fungal growth. Sauer, et., al., Composition of the Essential Oil of Oregano, ISBN 90-247-3195X; this study revealed that the oil of oregano inhibited E. Coli, Candida albicans, Staph, Pseudomonas and B.Subtilis. Didry, et., al., Pharmacy, 84(1193);11-4;301-303; this study indicated that carvacrol (the active ingredient of the oil of oregano) was effective on bacteria involved in upper respiratory infection.
THE FOLLOWING IS RECENT LABORATORY AND CLINICAL
INFORMATION REGARDING BIOTICS RESEARCH
AN EMULSIFIED EXTRACT OF OREGANO
IN A SUSTAINED RELEASE FORM
In vitro (laboratory) testing of A.D.P. versus Nystantin on the growth of candida albicans revealed equivalent inhibition at 4.5 mcl/ml and 136 units/ml levels (macrobroth culture). This is a reduction of 99.95 percent of controls.
In a clinical trial with A.D.P., 10 patients who met the criteria for candida infection (out of 200 who were examined and had symptoms) were selected for testing. Each of the ten patients had either a moderate +2, severe +3 or very severe, +4 infection. The average age was 38. No specific dietary suggestions were made; however, the group was asked to refrain from antibiotic use, yeast control remedies and vaginal douches during the four week test period.
All of the patients in the clinical trial reported improved sleep patterns, energy levels, and increased appetites. No major side effects were reported, such as abdominal cramps, nausea, or fever spikes. Nine of the ten patients indicated a desire to continue using the A.D.P., if required. Upon re-examination, after the four week period the following was found:
60% of the patients (6) had zero growth for candida.
30% of the patients (3) had a 50% of higher reduction from initial testing.
10% of patients of the patients (1) had no change.
1 tablet contains Oregano Oil (extract from leaf)......50 mg